Parallel Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,808
+71.3%
440
+61.8%
0.00%
Q2 2023$9,811
+94.6%
272
+106.1%
0.00%
Q1 2023$5,041
-42.8%
132
-14.8%
0.00%
Q4 2022$8,820
-19.8%
155
-44.2%
0.00%
-100.0%
Q3 2022$11,000
+22.2%
278
+42.6%
0.00%
Q2 2022$9,000
+50.0%
195
+25.0%
0.00%
Q1 2022$6,0000.0%156
+12.2%
0.00%
Q4 2021$6,000
-57.1%
139
-59.9%
0.00%
-100.0%
Q3 2021$14,000
+250.0%
347
+273.1%
0.00%
Q2 2021$4,000
-33.3%
93
-38.8%
0.00%
Q1 2021$6,000
+50.0%
152
+63.4%
0.00%
Q4 2020$4,000
-42.9%
93
-65.3%
0.00%
Q3 2020$7,0000.0%2680.0%0.00%
Q2 2020$7,000
+133.3%
268
+45.7%
0.00%
Q1 2020$3,0000.0%184
+5.1%
0.00%
Q4 2019$3,0000.0%1750.0%0.00%
Q3 2019$3,0000.0%1750.0%0.00%
Q2 2019$3,0001750.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders